Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Joan Schiller, MD
University of Texas
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
33 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hôpital Charles Lemoyne
Greenfield Park, Quebec, Canada
- Hospital Notre-Dame
Montreal, Quebec, Canada
- Krankenhaus Nordwest
Frankfurt, Frankfurt, Germany
- Krankenhaus Grosshansdorf
Grosshansdorf, Free and Hanseatic City of Hamburg, Germany
- Universitaetsklinikum Mainz
Mainz, Mainz, Germany
- Asklepios Klinik Gauting Gmbh
Gauting, Munich, Germany
- Klinikum Rechts Der Isar Der Tu München
München, Munich, Germany
- Achieve Clinical Research, Llc
Birmingham, Alabama, United States
- Clearview Cancer Institute
Huntsville, Alabama, United States
- Pacific Cancer Medical Center, Inc.
Anaheim, California, United States
- Cancer Care Associates of Fresno Medical Group Inc
Fresno, California, United States
- St. Joseph'S Hospital
Orange, California, United States
- Kaiser Permanente Medical Center
Vallejo, California, United States
- University of Colorado Denver School of Medicine
Aurora, Colorado, United States
- Florida Cancer Specialists
Fort Myers, Florida, United States
- Integrated Community Oncology Network
Jacksonville, Florida, United States
- H. Moffitt Lee Cancer Center
Tampa, Florida, United States
- Ingalls Memorial Hospital
Harvey, Illinois, United States
- Cancer Center of Kansas
Wichita, Kansas, United States
- Montgomery Cancer Center
Mount Sterling, Kentucky, United States
- Auerbach Hematology Oncology
Baltimore, Maryland, United States
- Karmanos Cancer Institute
Detroit, Michigan, United States
- Hematology Oncology Centers
Billings, Montana, United States
- Blumenthal Cancer Center
Charlotte, North Carolina, United States
- Kaiser Northwest
Portland, Oregon, United States
- South Carolina Oncology Associates
Columbia, South Carolina, United States
- the Jones Clinic
Germantown, Tennessee, United States
- Sarah Cannon Research Institute
Nashville, Tennessee, United States
- Ut Southwestern Medical Center
Dallas, Texas, United States
- Scott and White Memorial Hospital (texas A & M)
Temple, Texas, United States
- Swedish Cancer Institute
Seattle, Washington, United States
- Northwest Medical Specialties
Tacoma, Washington, United States
- University of Wisconsin
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2010
- Primary completion
- 30 Sept 2013
- Completion
- 30 Sept 2013
- Last update posted
- 26 Jan 2016
- Registered enrollment
- 116
- Registry id
- NCT01137968
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.